# Conexeu Sciences Inc.: overview CNXU · Nasdaq · CIK 2066836 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Oct 31 Pages: [Overview](/companies/cnxu.md) · [Financials](/companies/cnxu/financials.md) · [Filings](/companies/cnxu/filings.md) · [Insiders](/companies/cnxu/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.05)](/filings/0001062993-26-003207.md) | [(0.09)](/filings/0001062993-26-004935.md) | [(0.11)](/filings/0001062993-26-003207.md) | [(0.29)](/filings/0001062993-26-004935.md) | | Free cash flow | $k | not reported | [(574) d](/filings/0001062993-26-004935.md) | not reported | [(6,800) d](/filings/0001062993-26-004935.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure. ## Last five fiscal years Not reported. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cnxu/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $133.9k | 12,264 | | New +12,264 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $64.1k | 5,871 | | New +5,871 | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $57.0k | 5,219 | | New +5,219 | | [HOLLENCREST CAPITAL MANAGEMENT](/funds/1161722.md) | 2026-06-30 | $10.9k | 1,000 | | New +1,000 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $10.0k | 887 | | New +887 | | [Integrated Wealth Concepts LLC](/funds/1737109.md) | 2026-06-30 | $4.4k | 400 | | New +400 | | [JONES FINANCIAL COMPANIES LLLP](/funds/815917.md) | 2026-06-30 | $1.1k | 100 | | New +100 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $1.1k | 100 | | New +100 | ## Recent filings [All 88 filings](/companies/cnxu/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 16:30 ET | [8-K](/filings/0001062993-26-005569.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-005569 | | 2026-10-20 | 16:30 ET | [8-K](/filings/0001062993-26-005431.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-005431 | | 2026-09-15 | 17:25 ET | [SCHEDULE 13D/A](/filings/0001062993-26-004967.md) | Ownership report, active investor, amended | 0001062993-26-004967 | | 2026-09-14 | 16:30 ET | [10-Q](/filings/0001062993-26-004935.md) | Quarterly report, period 2026-07-31 | 0001062993-26-004935 | | 2026-09-10 | 16:30 ET | [8-K](/filings/0001062993-26-004891.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-004891 | | 2026-08-18 | 06:04 ET | [SCHEDULE 13D](/filings/0001062993-26-004475.md) | Ownership report, active investor | 0001062993-26-004475 | | 2026-07-07 | 17:12 ET | [8-K](/filings/0001062993-26-003545.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-003545 | | 2026-06-15 | 16:30 ET | [10-Q](/filings/0001062993-26-003207.md) | Quarterly report, period 2026-04-30 | 0001062993-26-003207 | | 2026-06-09 | 16:30 ET | [8-K](/filings/0001062993-26-003128.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-003128 | | 2026-05-15 | 16:22 ET | [8-K](/filings/0001062993-26-002703.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001062993-26-002703 | ## Latest annual report No annual report is in coverage. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 2066836 - Tickers: CNXU - Exchange: Nasdaq - SIC code: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:31 ET. No prices; not investment advice.